We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eyenovia Inc | NASDAQ:EYEN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.0826 | 8.81% | 1.02 | 0.96 | 1.22 | 1.14 | 0.9374 | 0.95 | 2,484,767 | 05:00:11 |
From May 2019 to May 2024
Details of the presentation are below:
Event: 22nd Annual H.C. Wainwright Global Investment ConferenceDate: Tuesday, September 15, 2020Presentation Time: 2:30-2:50 PM ET
About Eyenovia, Inc.
Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more Information, please visit www.eyenovia.com.
Company Contact:Eyenovia, Inc.John GandolfoChief Financial Officerjgandolfo@eyenovia.com
Investor Contact:The Ruth GroupCarol RuthPhone: 646-536-7004cruth@theruthgroup.com
1 Year Eyenovia Chart |
1 Month Eyenovia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
